03/25/2025 5:55 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/25/2025 5:57 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/25/2025 6:00 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2025 10:39 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025 7:38 AM | HIRSCHMAN ORIN (Filed by) KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025 4:22 PM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:17 PM | KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject) Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
11/14/2024 3:53 PM | KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject) Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024 3:32 PM | Alyeska Investment Group, L.P. (Filed by) KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject)
| Form SC 13G | |
11/13/2024 4:34 PM | KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject) Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A | |
11/08/2024 6:00 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for KPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
11/08/2024 6:01 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 6:00 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:32 AM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Stengone Carmine N. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:02 AM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Shapiro Aron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 12:00 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Walters-Hoffert Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 2:45 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) TYLE PRAVEEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 3:17 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Tosca Melissa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 6:01 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024 6:01 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 6:02 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 2:15 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) TYLE PRAVEEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:15 PM | Hollander David (Reporting) KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:15 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Walters-Hoffert Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:15 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Shapiro Aron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:15 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Parsons Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:16 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Stengone Carmine N. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:16 PM | Daniels Eric Joseph (Reporting) KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:16 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Walters-Hoffert Lisa (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/03/2024 2:16 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Tosca Melissa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 2:16 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Strem Brian M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:00 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:47 PM | KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer) Tosca Melissa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 2:40 PM | Daniels Eric Joseph (Reporting) KIORA PHARMACEUTICALS INC (Issuer) Kiora Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:02 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 2:43 PM | KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/29/2024 2:47 PM | KIORA PHARMACEUTICALS INC (Subject) Kiora Pharmaceuticals (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/10/2024 5:59 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024 6:00 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 6:01 AM | KIORA PHARMACEUTICALS INC (Filer) Kiora Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |